期刊文献+

萘醌类化合物对HL-7702细胞LDH释放率以及线粒体膜电位的影响 被引量:10

Changes of LDH Release Rate and Mitochondrial Membrane Potential of HL-7702 Cells Exposed to Naphthoquinones
下载PDF
导出
摘要 测定了6种萘醌类化合物对正常人肝细胞HL-7702乳酸脱氢酶(Lactate Dehydrogenase,LDH)释放率以及线粒体膜电位的影响.研究发现,LDH释放率随着染毒浓度的增大而增大,而线粒体膜电位却减小,呈现剂量-效应关系.其中,2-羟基-1,4-萘醌引起的LDH释放率变化高于其它4种化合物,而阿托伐醌引起的线粒体膜电位下降最严重,这可能是由于阿托伐醌是高脂溶性的化合物,更容易到达细胞靶点从而引起了严重的细胞凋亡所致.脂水分配系数lgP、分子直径D以及分子拓扑学指数TIndex可能是影响该类化合物对HL-7702致毒作用的主要因素.该类化合物还可能通过疏水作用或者π-π相互作用影响生物大分子,从而产生毒性作用. The effects of six naphthoquinone compounds, including atovaquone, buparvaquone, 2-hydroxy-1,4-naphthoquinone, menadione, 2-acetoxy-1,4-naphthoquinone and 2-ethoxy-1,4-naph- thoquinone, on LDH Release Rate and Mitochondrial Membrane Potential of HL-7702 Cells were stud- ied. The results showed that the LDH release rates increased while mitochondrial membrane potential reduced with the increase of concentrations. 2-Hydroxy-1,4-naphthoquinone has caused the highest LDH release rate while atovaquone lead to the seriously decline of mitochondrlal membrane potential. It maybe due to the highly lipid solubility of atovaquone which can cause serious apoptosis, lgP, Diam- eter and topological index played an important role in the toxicity of naphthoquinones to HL-7702 cells. At the same time, hydrophobic interaction and π-π interaction may exist between naphthoquinones and biomacromolecules.
出处 《南开大学学报(自然科学版)》 CAS CSCD 北大核心 2012年第4期6-12,共7页 Acta Scientiarum Naturalium Universitatis Nankaiensis
基金 国家自然科学基金青年基金项目(21007045)
关键词 萘醌类化合物 HL-7702细胞 乳酸脱氢酶 线粒体膜电位 致毒机理 naphthoquinones HL-7702 cell LDH mitochondrial membrane potential toxicity mechanism
  • 相关文献

参考文献4

二级参考文献40

  • 1Anzebacher P, Anzenbacherova E. Cytochrome P450 and metabolism of xenobiotics. Cell Mol Life Sci, 2001, 58:737--747.
  • 2Sono M, Roach M P, Coulter E D, et al. Heine-containing oxygenases. Chem Rev, 1996, 96:2841 --2887.
  • 3Guengerich F P. Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem Res Toxicol, 2001, 14:611--650.
  • 4Williams P A, Cosme J L. Mammalian microsomal cytochrome P450 monooxygenase: Structural adaptations for membrane binding and functional diversity. Mol Cell, 2000, 5: 121 -- 131.
  • 5Lewis D F, Jacobs M N, Dickins M. Compound lipophilicity for substrate binding to human P450s in drug metabolism. Drug Discov Today, 2004, 9:530--537.
  • 6Kirton S B, Murray C W, Verdonk M L, et al. Prediction of binding modes for ligands in the cytochrome P450 and other heme-containing proteins. Proteins, 2005, 58:836--844.
  • 7Stiborova M, Sopko B, Hodek P, et al. The binding of aristolochic acid I to the active site of human cytochromes P450 1A1 and 1A2 explains their potential to reductively activate this human carcinogen. Cancer Lett, 2005, 229:193--204.
  • 8Ito Y, Kondo H, Goldfarb P S, et al. Analysis of CYP2D6 substrate interactions by computational methods. J Mol Graph Model, 2008, 26: 947--956.
  • 9Keizers P H, Lussenburg B M, de Graaf C, et al. Influence ofphenylalanine 120 on cytochrome P450 2D6 catalytic selectivity regiospecificity: crucial role in 7-methoxy-4-(aminomethyl)-coumarn metabolism. Biochem Pharmacol, 2004, 68:2263--2271.
  • 10Lussenburg B M, Keizers P H, de Graaf C, et al. The role of plaenylalanine 483 in cytochrome P450 2D6 is strongly substrate dependent, Biochem Pharmacol, 2005, 70:1253--1261.

共引文献23

同被引文献99

引证文献10

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部